Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of attenuated erythromycin‐resistant Streptococcus agalactiae vaccine for tilapia ( Oreochromis niloticus ) culture

20 Mar 2019

Abstract excerpt

Abstract Streptococcus agalactiae is an important pathogen in fish, causing great losses of intensive tilapia farming. To develop a potential live attenuated vaccine, a re‐attenuated S. agalactiae (named TFJ‐ery) was developed from a natural low‐virulence S. agalactiae strain TFJ0901 through selection of resistance to erythromycin. The biological characteristics, virulence, stability and the immunization...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aquaculture disease management and microbiota
Share to Neonatal and Maternal Infections
Share to Vibrio bacteria research studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30893488
DOI: 10.1111/jfd.12977

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of attenuated erythromycin‐resistant Streptococcus agalactiae vaccine for tilapia ( Oreochromis niloticus ) culturePMID 30893488Read ↗

Potential of naturally attenuated Streptococcus agalactiae as a live vaccine in Nile tilapia (Oreochromis niloticus)Semantic proximity Read ↗

Efficacy of α-enolase-based DNA vaccine against pathogenic Streptococcus iniae in Nile tilapia (Oreochromis niloticus)Semantic proximity Read ↗

Characterization of Streptococcus iniae ghost vaccine and its immunization in Nile tilapia (Oreochromis niloticus)Semantic proximity Read ↗

Advances in vaccines developed for bacterial fish diseases, performance and limitsSemantic proximity Read ↗

Virulence genes contributing to Aeromonas veronii pathogenicity in Nile tilapia (Oreochromis niloticus): approaching the development of live and inactivated vaccinesSemantic proximity Read ↗

CRISPR-Cas9-Mediated Construction of a Streptococcus agalactiae Vaccine for Tilapia and Evaluation of Its Protective EfficacySemantic proximity Read ↗

Analysis of the efficacy of two molecular adjuvants,flagellin and IFN-γ,on the immune response against Streptococcus agalactiae in Nile tilapia (Oreochromis niloticus)Semantic proximity Read ↗

Persistence of a single clone of Streptococcus agalactiae causing disease in tilapia (Oreochromis sp.) cultured in Colombia over 8 yearsSemantic proximity Read ↗

Maternal immunity of tilapia broodstock vaccinated with polyvalent vaccine and resistance of their offspring against Streptococcus agalactiaeSemantic proximity Read ↗

Screening vaccine candidate strains against Streptococcus agalactiae of tilapia based on PFGE genotype.Semantic proximity Read ↗

Pathogenicity of <em>Aeromonas veronii</em> from Nile Tilapia (<em>Oreochromis niloticus</em>) and Efficacy of Fish Oral Vaccine against Motile Aeromonad Septicemia in Tank TrialsSemantic proximity Read ↗

Capsular polysaccharide of Streptococcus agalactiae is an essential virulence factor for infection in Nile tilapia (Oreochromis niloticus Linn.)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.